Portfolio data

Browse all portfolio data news

    Latest portfolio data news

    Show news from

    Kesmalea Therapeutics Appoints Industry Veteran Tim Clackson to Board of Directors

    Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation

    Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer

    OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

    Purespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024

    Search